TLM-101 by Therillume for Neurofibromatoses Type I (Von Recklinghausen’s Disease): Likelihood of Approval

TLM-101 is under clinical development by Therillume and currently in Phase I for Neurofibromatoses Type I (Von Recklinghausen’s Disease).

Source link
#TLM101 #Therillume #Neurofibromatoses #Type #Von #Recklinghausens #Disease #Likelihood #Approval